AI-generated summary
This study protocol describes a planned multicenter randomized trial of bright light therapy for adults with unipolar or bipolar depression. Participants will be assigned to home-based light therapy, light therapy in a social LightCafé setting, or LightCafé therapy with personalized light and darkness timing using blue light blocking glasses. The authors describe a protocol only and report no results.
- Participants
- 231
- Who or what was studied
- Adults with unipolar or bipolar depression currently experiencing a depressive episode
- Limits stated in the abstract
- This is a study protocol with no results reported, so no treatment effects can be inferred from the abstract.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Bright Light Therapy (BLT) is an effective treatment for various mood disorders, but challenges remain in optimizing its real-world administration, predicting individual responses, and understanding its mechanisms.
Methods
This multicenter randomized controlled trial will enroll 231 patients with unipolar or bipolar depression, all currently experiencing a depressive episode. Participants will be randomized to one of three BLT
Interventions
(1) traditional home-based BLT, (2) BLT administered in the LightCafé-a novel setting promoting social interaction and lifestyle support, or (3) LightCafé BLT with personalized timing of both light and darkness by adding the use of blue light blocking glasses. The treatment duration will range from one to three weeks, based on preset definitions of participant's response. The primary outcome is the change in depressive symptoms, assessed by a blinded rater. Secondary outcomes include subjective and objective sleep measures, circadian rhythm parameters from melatonin patterns and actigraphy, and functional outcomes. Change processes will be assessed using ecological momentary assessments of daily affect and energy levels, light exposure sensors, and via brain imaging.
Discussion
This trial is the first to directly compare different BLT administration models, including a LightCafé setting. It aims to identify predictors of BLT response, investigate chronobiological and neurobiological mechanisms, and provide insights to optimize BLT for diverse patient populations. The results will inform clinical guidelines and enhance BLT's accessibility and effectiveness.
Trial Registration
Registered on July 14, 2023, at clinicaltrials.gov under number NCT05958940.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Depression, Randomized controlled trial, Trial registration, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.